Agarwal R, Chakrabarti A. Allergic bronchopulmonaryaspergillosis in asthma: epidemiological, clinical and therapeutic issues. Future Microbiol 2013;8:1463-74.
Agarwal R. What is the current place of azoles in allergic bronchopulmonary aspergillosis and severe asthma with fungal sensitization. Expert Rev Respir Med 2012;6:363-76.
Agarwal R, Gupta D, Aggarwal AN, Behera D, Jindal SK. Allergic bronchopulmonary aspergillosis: lessons from 126 patients attending a chest clinic in north India. Chest 2006;130:442-8.
Lebond T, Tonnel AB. Allergic bronchopulmonary aspergillosis and an evidence based review of azoles in treatment. Allergy 2005;60:1004-13.
Wark P. Pathogenesis of allergic bronchopulmonary aspergillosis and an evidence based review of azoles in treatment. Respir Med 2004;98:915-23.
Stavens DA, Schwartz HJ, Lee JY, Moskovitz BL, Jerome DC, Catanzaro A, et al. A randomized trial of itraconazole in allergic bronchopulmonary aspergillosis. N Engl J Med 2000;342:756-62.
Wark P, Hensley MJ, Saltos N, Boyle MJ, Toneguzzi RC, Epid GD, et al. Anti-inflammatory effect of itraconazole in stable allergic bronchopulmonary aspergillosis: a randomized controlled trial. J Allergy Clin Immunol 2003;111:952-7.
Chishimba L, Niven RM, Cooley J, Denning DW. Voriconazole and posaconazole improve asthma severity in allergic bronchopulmonary aspergillosis and severe asthma with fungal sensitization. J Asthma 2012;49:423-33.
Aggarwal R. Allergic bronchopulmonary aspergillosis. Chest 2009;135:805-26.
